Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Newcomb

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Structure (London, England : 1993)|July 15, 1999
Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitorsX Zhu, J L Kim, J R Newcomb, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 2, 2003
In vitro immunomodulatory activity of ruthenium complexesJ R Newcomb, B Rivnay, C M Bastos, et al.
Molecular Immunology|April 1, 1997
Affinity and kinetics of the interactions between an alphabeta T-cell receptor and its superantigen and class II-MHC/peptide ligandsS S Khandekar, P P Brauer, J W Naylor, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Structure (London, England : 1993)|July 15, 1999
Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitorsX Zhu, J L Kim, J R Newcomb, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 2, 2003
In vitro immunomodulatory activity of ruthenium complexesJ R Newcomb, B Rivnay, C M Bastos, et al.
Molecular Immunology|April 1, 1997
Affinity and kinetics of the interactions between an alphabeta T-cell receptor and its superantigen and class II-MHC/peptide ligandsS S Khandekar, P P Brauer, J W Naylor, et al.
Pageof 2